Medical aspects of UPE research in the middle ultraviolet range (mitogenetic radiation)
Elena V. Naumova, 1, Mayra V. Aristanbekova, 2, Ilya V. Volodyaev, 3
1 Rzhanov Institute of Semiconductor Physics, Siberian Branch of Russian Academy of Sciences, Novosibirsk, Russia
2 Saratov Regional Center for the Prevention and Control of AIDS, Saratov, Russian Federation
3 Faculty of Biology, Moscow State University, Moscow, Russia
Abstract
Here we review the medicine-related results obtained by early researchers of mitogenetic radiation (ultra-weak photon emission in the middle-ultraviolet range). Both experimental and clinical data are presented and analyzed. Cancer research and diagnostics stands along among the medical applications of UV-UPE as the best-studied and the most interesting for fundamental and applied science. The researchers of mitogenetic radiation were the first who claimed existence of a peptide tumour marker in blood. Their research was interrupted by the end of 1940-s in spite of the high efficiency of cancer diagnostics shown in the leading USSR oncological clinics (the sensitivity and specificity claimed by the authors is over 95%). Results on UPE of blood and other physiological fluids and tissues in pathological and physiological states are briefly reviewed. Some prominent results were later confirmed by other methods, some major claims have not been validated by now, but surely deserve revising and testing for validity. The review covers published and unpublished materials from the scientific archive by A.G. Gurwitsch and his scientific dynasty.
Speaker
Elena V. Naumova
Rzhanov Institute of Semiconductor Physics, Siberian Branch of Russian Academy of Sciences, Novosibirsk, Russia
Russia
Discussion
Ask question
